Completed
Safety Study of IPI-504 in Patients With Relapsed and Relapsed Refractory Multiple Myeloma
NCT00113204
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +18 more
- Locations
-
- Johns Hopkins Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- Hackensack University Medical Center The David Jurist Research Center Hackensack, New Jersey, United States
- St. Vincent's Comprehensive Cancer Center New York, United States